Joshua J. Souchek, Ph.D. - Publications

Affiliations: 
2013 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Oncology, Pharmacy, Biochemistry

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 File N, Carmicheal J, Krasnoslobodtsev AV, Japp NC, Souchek JJ, Chakravarty S, Hollingsworth MA, Sasson AA, Natarajan G, Kshirsagar PG, Jain M, Hayashi C, Junker WM, Kaur S, Batra SK. Substituent Effects Impact Surface Charge and Aggregation of Thiophenol-Labeled Gold Nanoparticles for SERS Biosensors. Biosensors. 12. PMID 35049653 DOI: 10.3390/bios12010025  0.626
2021 Japp NC, Souchek JJ, Sasson AR, Hollingsworth MA, Batra SK, Junker WM. Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection. Journal of Immunology Research. 2021: 9942605. PMID 34514003 DOI: 10.1155/2021/9942605  0.646
2018 Souchek JJ, Wojtynek NE, Payne WM, Holmes MB, Dutta S, Qi B, Datta K, LaGrange CA, Mohs AM. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft. Acta Biomaterialia. PMID 29890268 DOI: 10.1016/J.Actbio.2018.06.016  0.354
2018 Qi B, Crawford AJ, Wojtynek NE, Holmes MB, Souchek JJ, Almeida-Porada G, Ly QP, Cohen SM, Hollingsworth MA, Mohs AM. Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29325740 DOI: 10.1016/J.Nano.2017.12.015  0.405
2017 Gunda V, Souchek JJ, Abrego J, Shukla SK, Goode GD, Vernucci E, Dasgupta A, CHaika N, King RJ, Li S, Wang S, Yu F, Bessho T, Lin C, Singh PK. MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28720669 DOI: 10.1158/1078-0432.Ccr-17-1151  0.409
2017 Souchek JJ, Davis AL, Hill TK, Holmes MB, Qi B, Singh PK, Kridel SJ, Mohs AM. Combination treatment with orlistat-containing nanoparticles and taxanes is synergistic and enhances microtubule stability in taxane-resistant prostate cancer cells. Molecular Cancer Therapeutics. PMID 28615298 DOI: 10.1158/1535-7163.Mct-17-0013  0.41
2017 Seshacharyulu P, Baine MJ, Souchek JJ, Menning M, Kaur S, Yan Y, Ouellette MM, Jain M, Lin C, Batra SK. Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochimica Et Biophysica Acta. PMID 28249796 DOI: 10.1016/J.Bbcan.2017.02.003  0.649
2017 Gunda V, Souchek J, Abrego J, Goode G, Vernucci E, Shukla SK, DasGupta A, Chaika NV, King R, Yu F, Bessho T, Lin C, Shou W, Sicong L, Singh PK. Abstract 459: Targeting MUC1 mediated nucleotide metabolism sensitizes pancreatic tumors to radiation therapy Cancer Research. 77: 459-459. DOI: 10.1158/1538-7445.Am2017-459  0.363
2016 Hill TK, Kelkar SS, Wojtynek NE, Souchek JJ, Payne WM, Stumpf K, Marini FC, Mohs AM. Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery. Theranostics. 6: 2314-2328. PMID 27877237 DOI: 10.7150/Thno.16514  0.345
2015 Shukla SK, Dasgupta A, Mehla K, Gunda V, Vernucci E, Souchek J, Goode G, King R, Mishra A, Rai I, Nagarajan S, Chaika NV, Yu F, Singh PK. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. PMID 26510913 DOI: 10.18632/Oncotarget.5843  0.431
2015 Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. PMID 26046375 DOI: 10.18632/Oncotarget.4078  0.518
2014 Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. British Journal of Cancer. 111: 1139-49. PMID 25025965 DOI: 10.1038/Bjc.2014.385  0.649
2013 Torres MP, Rachagani S, Souchek JJ, Mallya K, Johansson SL, Batra SK. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. Plos One. 8: e80580. PMID 24278292 DOI: 10.1371/Journal.Pone.0080580  0.488
2013 Horn A, Chakraborty S, Dey P, Haridas D, Souchek J, Batra SK, Lele SM. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Archives of Pathology & Laboratory Medicine. 137: 546-51. PMID 23544943 DOI: 10.5858/Arpa.2011-0229-Oa  0.569
2013 Shimizu T, Torres MP, Chakraborty S, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ, Batra SK. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Cancer Letters. 336: 270-80. PMID 23523869 DOI: 10.1016/J.Canlet.2013.03.017  0.493
2013 Souchek J, Chakraborty S, Rachagani S, Hauke R, Batra S. Glucocorticoids augment resistance to gemcitabine in pancreatic cancer cells Pancreatology. 13: e75. DOI: 10.1016/J.Pan.2012.12.316  0.498
2012 Torres MP, Chakraborty S, Souchek J, Batra SK. Mucin-based targeted pancreatic cancer therapy. Current Pharmaceutical Design. 18: 2472-81. PMID 22372499 DOI: 10.2174/13816128112092472  0.537
2011 Graham RP, Dry S, Li X, Binder S, Bahrami A, Raimondi SC, Dogan A, Chakraborty S, Souchek JJ, Folpe AL. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study. The American Journal of Surgical Pathology. 35: 1615-25. PMID 21997683 DOI: 10.1097/Pas.0B013E3182284A3F  0.33
2010 Souchek JJ, Chakraborty S, Rachagani S, Hauke R, Batra SK. Abstract 722: Reciprocal regulation of MUC4 and HER-2 by the corticosteroid fluticasone propionate in pancreatic cancer cells: Potential role in anticancer therapy Cancer Research. 70: 722-722. DOI: 10.1158/1538-7445.Am10-722  0.521
2010 Xiao Y, Gao X, Cheung W, Urbas A, Taratula O, Holbrook D, Cavicchi RE, Souchek JJ, Wagner PD, Srivastava S, Avedisian T, He H, Batra S. Abstract 3686: Antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast and pancreas cancer cells Cancer Research. 70: 3686-3686. DOI: 10.1158/1538-7445.Am10-3686  0.519
Show low-probability matches.